Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.

Carla Oliveira; Sérgia Velho; Enric Domingo; Ana Preto; Robert M W Hofstra; Richard Hamelin; Hiroyuki Yamamoto; Raquel Seruca; Simo Schwartz

doi:10.1038/sj.onc.1208906

Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.

Identifier:nobleid.org/w1/20260515/ACE571F2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ACE571F2.svg?ark=w1%2F20260515%2FACE571F2)](https://nobleid.org/work/w1/20260515/ACE571F2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.

Identifier:nobleid.org/w1/20260515/ACE571F2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ACE571F2.svg?ark=w1%2F20260515%2FACE571F2)](https://nobleid.org/work/w1/20260515/ACE571F2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work